Liz Arnold
Principal
Kea Advisory
Bio:
Liz is a strategic biopharma leader whose experience uniquely spans the full development and commercialization continuum - from pre-IND and early clinical development through launch, commercialization, and lifecycle management. She has shaped asset, portfolio, and enterprise decisions by bringing commercial and market perspectives to development strategy, indication prioritization, evidence generation, launch planning, lifecycle strategy, and investment decisions. She has a strong track record in rare disease and in leading complex, cross-functional initiatives, and is passionate about translating innovative science into meaningful outcomes for patients.